After a century of false starts, scientists believe they have found a way to make cells burn more energy without the ...
According to MarketsandMarkets™, the Cell Culture Vessels Market is projected to grow from about USD 5.10 billion in 2025 to ...
Autolus Therapeutics is working with Cellares to assess automated CAR T manufacturing to support rising demand for its ...
Autolus Therapeutics, a commercial-stage biopharmaceutical company, has announced plans to assess the feasibility of Cellares ...
Scientists may have found a safer way to make cells burn more calories—by turning up the heat inside our cellular power plants.
Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, and Cellares Corp, the first ...
According to MarketsandMarkets, the Cell Culture Vessels Market is projected to grow from about USD 5.10 billion in 2025 to USD 8.03 billion ...
As the immune system weakens with age, scientists have found a way to restore some of its lost strength. By delivering mRNA ...
Autolus will evaluate Cellares' fully automated, high-throughput manufacturing platform in preparation for expansion into new indications Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage ...
Scientists are literally turning back the clocks in our cells, with the first drugs about to go to human trials ...
News-Medical.Net on MSN
Reprogramming immunity to protect beta cells in type 1 diabetes
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback